Agenda Dialogues AM26: Scaling AI: Now Comes the Hard Part
Jan 20, 2026
In this engaging discussion, Roy Jakobs, CEO of Royal Philips, emphasizes AI's role in enhancing patient care, while Julie Sweet of Accenture discusses its transformative impact on pharma regulations. Ryan McInerney from Visa paints a picture of future commerce enabled by AI with trusted agents, and Amin Nasser of Saudi Aramco shares insights on AI's value in energy operations. The panel highlights crucial lessons in scaling AI, urging a focus on data foundations and leadership to unlock its full potential.
AI Snips
Chapters
Transcript
Episode notes
AI Gives Clinicians Time Back
- AI can return clinicians meaningful time by automating documentation and routine workflows.
- That time increases quality patient interactions and improves clinical outcomes.
Standardize Content To Speed Time-to-Market
- Standardize processes and content to compress cycles from months to days.
- Then redeploy human time to assess impact and get products or treatments to the right people.
Agentic Commerce Needs Trust Layers
- Agentic commerce will let users shop and complete purchases natively inside AI platforms.
- That shift requires new trust mechanisms between users, agents, merchants, and banks.